Inventor · disambiguated record
Gary Anderson
Also filed as: ANDERSON GARY · ANDERSON GARY D
10 granted patents·4 pending applications·719 citations·filing 1995–2020
92Inventor score
Technology areasA61P
Top patents by PatentIndex Score
14 records- 0196US6136839ATreatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitorSEARLE & CO·Filed 1996·Granted Oct 24, 2000·356 cites·22 claims
- 0291US5990148ATreatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorSEARLE & CO·Filed 1996·Granted Nov 23, 1999·95 cites·12 claims
- 0391US5700816ATreatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorFiled 1995·Granted Dec 23, 1997·131 cites·21 claims
- 0489US6617345B1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporinSEARLE & CO·Filed 2000·Granted Sep 9, 2003·35 cites·11 claims
- 0589US6407140B1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorSEARLE & CO·Filed 2000·Granted Jun 18, 2002·39 cites·20 claims
- 0675US7132441B2Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitorSEARLE & CO·Filed 2002·Granted Nov 7, 2006·9 cites·18 claims
- 0773US6342510B1Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonistSEARLE & CO·Filed 1996·Granted Jan 29, 2002·32 cites·14 claims
- 0870US7141599B2Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporinPHARMACIA CORP·Filed 2003·Granted Nov 28, 2006·6 cites·4 claims
- 0955US6172096B1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonistSEARLE & CO·Filed 1998·Granted Jan 9, 2001·10 cites·6 claims
- 1055US2005043355A1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1149US2003004191A1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitorPHARMACIA CORP·Filed 2002·Application pending·0 cites
- 1246US6376528B1Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitorSEARLE & CO·Filed 1999·Granted Apr 23, 2002·6 cites·9 claims
- 1346US2002107276A1Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonistPHARMACIA CORP·Filed 2002·Application pending·0 cites
- 1443US2022168387A1Inhaled administration of lipocalin muteinsPIERIS PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gary Anderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →